Illumina and Genomics England partnership sequences 50,000 genomes

The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes.  

Of those 50,000 genomes sequenced so far, 8,000 are for cancer patients and 42,000 for rare diseases. Breast, brain, colorectal, lung, prostate and renal are among those cancers to have been successfully sequenced.

While many developed countries are working on genomic medicine initiatives, no other has the reach and impact of the 100,000 Genomes Project. Learn more about this landmark milestone,here.